Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

Keyphrases

• Patient Outcomes 100%
• GARFIELD-AF 100%
• 2-year Outcome 100%
• New-onset Atrial Fibrillation 100%
• Paroxysmal Atrial Fibrillation 100%
• Anticoagulation 66%
• Antithrombotic Therapy 66%
• Stroke/systemic Embolism 66%
• Respiratory Infection 33%
• Sepsis 33%
• Most Common Cause 33%
• Cause of Death 33%
• Risk Profile 33%
• Improved Outcomes 33%
• Anticoagulant Therapy 33%
• Antiplatelet Therapy 33%
• Baseline Characteristics 33%
• Malignancy 33%
• Mean Standard Deviation 33%
• First Year 33%
• Low Risk 33%
• Newly Diagnosed 33%
• All-cause Mortality 33%
• Characteristic Risk 33%
• Respiratory Failure 33%
• Antiplatelet Monotherapy 33%
• Cause-specific 33%
• Specific Risk 33%
• Acute Coronary Syndrome 33%
• Major Bleeding 33%
• Anticoagulant Treatment 33%
• Major Events 33%
• Risk of Death 33%
• CHA2DS2-VASc Score 33%
• Stroke Causes 33%
• Congestive Heart Failure 33%
• 2-year Follow-up 33%
• Comprehensive Approach 33%
• 95% Confidence Interval 33%
• Mortality Risk Factors 33%
• Intervention Targets 33%

Medicine and Dentistry

• Atrial Fibrillation 100%
• Apoplexy 50%
• Anticoagulation 50%
• Antithrombotic Therapy 50%
• Antiplatelet 50%
• Anticoagulant Therapy 50%
• Embolism 50%
• Respiratory Tract Infection 25%
• Sepsis 25%
• Cancer 25%
• All Cause Mortality 25%
• Monotherapy 25%
• CHA2DS2-VASc Score 25%
• Respiratory Failure 25%
• Major Bleeding 25%
• Observational Study 25%
• Congestive Heart Failure 25%
• Acute Coronary Syndrome 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Anticoagulant Agent 50%
• Antiplatelet 50%
• Antithrombotic Therapy 50%
• Cerebrovascular Accident 50%
• Embolism 50%
• Respiratory Tract Infection 25%
• Sepsis 25%
• Monotherapy 25%
• Bleeding 25%
• Acute Coronary Syndrome 25%
• Observational Study 25%
• Congestive Heart Failure 25%
• Respiratory Failure 25%
• All Cause Mortality 25%